Jie Kai Tee

1.3k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Jie Kai Tee is a scholar working on Epidemiology, Biomaterials and Hepatology. According to data from OpenAlex, Jie Kai Tee has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Biomaterials and 4 papers in Hepatology. Recurrent topics in Jie Kai Tee's work include Nanoparticle-Based Drug Delivery (4 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Jie Kai Tee is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Jie Kai Tee collaborates with scholars based in Singapore, France and Australia. Jie Kai Tee's co-authors include Han Kiat Ho, David Tai Leong, Magdiel Inggrid Setyawati, Fei Peng, Xianguang Ding, Jinping Wang, Min En Nga, Pu Chun Ke, Boon‐Huat Bay and Choon Nam Ong and has published in prestigious journals such as Chemical Society Reviews, Nature Communications and Nature Nanotechnology.

In The Last Decade

Jie Kai Tee

13 papers receiving 1.1k citations

Hit Papers

Nanoparticles promote in vivo breast cancer cell intravas... 2019 2026 2021 2023 2019 100 200 300 400

Peers

Jie Kai Tee
Luyao Sun China
Reju George Thomas South Korea
Dania Movia Ireland
Sandro Sieber Switzerland
Hang Hu China
Jie Kai Tee
Citations per year, relative to Jie Kai Tee Jie Kai Tee (= 1×) peers Weiqi Zhang

Countries citing papers authored by Jie Kai Tee

Since Specialization
Citations

This map shows the geographic impact of Jie Kai Tee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Kai Tee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Kai Tee more than expected).

Fields of papers citing papers by Jie Kai Tee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Kai Tee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Kai Tee. The network helps show where Jie Kai Tee may publish in the future.

Co-authorship network of co-authors of Jie Kai Tee

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Kai Tee. A scholar is included among the top collaborators of Jie Kai Tee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Kai Tee. Jie Kai Tee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Setyawati, Magdiel Inggrid, Qin Wang, Nengyi Ni, et al.. (2023). Engineering tumoral vascular leakiness with gold nanoparticles. Nature Communications. 14(1). 4269–4269. 64 indexed citations
2.
Tee, Jie Kai, et al.. (2020). An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage. International Journal of Molecular Sciences. 21(10). 3714–3714. 12 indexed citations
3.
Peng, Fei, Magdiel Inggrid Setyawati, Jie Kai Tee, et al.. (2019). Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness. Nature Nanotechnology. 14(3). 279–286. 408 indexed citations breakdown →
4.
Tee, Jie Kai, Magdiel Inggrid Setyawati, Peng Fei, David Tai Leong, & Han Kiat Ho. (2019). Angiopoietin-1 accelerates restoration of endothelial cell barrier integrity from nanoparticle-induced leakiness. Nanotoxicology. 13(5). 682–700. 38 indexed citations
5.
Tee, Jie Kai, et al.. (2019). Nanoparticles' interactions with vasculature in diseases. Chemical Society Reviews. 48(21). 5381–5407. 267 indexed citations
6.
Baek, Jong-Suep, Jie Kai Tee, Yi Pang, et al.. (2018). Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson’s Disease. NeuroMolecular Medicine. 20(2). 262–270. 12 indexed citations
7.
Tee, Jie Kai, Fei Peng, & Han Kiat Ho. (2018). Effects of inorganic nanoparticles on liver fibrosis: Optimizing a double-edged sword for therapeutics. Biochemical Pharmacology. 160. 24–33. 27 indexed citations
8.
Tee, Jie Kai, et al.. (2018). Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2. Frontiers in Pharmacology. 9. 1018–1018. 21 indexed citations
9.
Tan, Justin, Jie Kai Tee, Jing Pan, et al.. (2018). Impact of substrate stiffness on dermal papilla aggregates in microgels. Biomaterials Science. 6(6). 1347–1357. 14 indexed citations
10.
Peng, Fei, Jie Kai Tee, Magdiel Inggrid Setyawati, et al.. (2018). Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis. ACS Applied Materials & Interfaces. 10(38). 31938–31946. 44 indexed citations
11.
Tee, Jie Kai, et al.. (2018). Titanium Dioxide Nanoparticles Enhance Leakiness and Drug Permeability in Primary Human Hepatic Sinusoidal Endothelial Cells. International Journal of Molecular Sciences. 20(1). 35–35. 24 indexed citations
12.
Liu, Yuanjie, Jie Kai Tee, & Gigi Ngar Chee Chiu. (2015). Dendrimers in Oral Drug Delivery Application: Current Explorations, Toxicity Issues and Strategies for Improvement. Current Pharmaceutical Design. 21(19). 2629–2642. 28 indexed citations
13.
Tee, Jie Kai, Choon Nam Ong, Boon‐Huat Bay, Han Kiat Ho, & David Tai Leong. (2015). Oxidative stress by inorganic nanoparticles. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 8(3). 414–438. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026